Gates Foun­da­tion sets up biotech-like in­sti­tute in hands-on ef­fort to spur drug de­vel­op­ment for ne­glect­ed dis­eases

BOSTON — Af­ter years of care­ful­ly dol­ing out mon­ey to spur drug de­vel­op­ment, the Bill and Melin­da Gates Foun­da­tion is of­fi­cial­ly get­ting its hands dirty with the busi­ness, clin­i­cal and reg­u­la­to­ry work nec­es­sary to bring drugs to mar­ket.

The new ef­fort takes the shape of what has been named the Bill and Melin­da Gates Med­ical Re­search In­sti­tute, which will func­tion in much the same way as its biotech neigh­bors in Cam­bridge, MA ex­cept in one re­gard: It will not seek to make mon­ey.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER